drugset / Trial / NCT01982201

Antacid Interaction Study

NCT01982201 ↗

Phase 1 Completed 24 enrolled Ardea Biosciences, Inc.
RandomizedParallel-groupOpen-labelBasic science

Summary

This study will assess the potential effects of calcium carbonate and aluminum/magnesium hydroxide-containing antacids on the pharmacokinetics (PK) and pharmacodynamics (PD) of lesinurad in healthy, adult male subjects.

Timeline

Start
2013-11
Primary completion
2013-12
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Lesinurad Small molecule 400 mg —
Subject MINTOX Unknown 10 ml —
Subject Tums Unknown 500 mg —
Subject Tums Unknown 750 mg —

Indications

No indication recorded.